Top Markets
Coin of the day
Nuformix plc Nuformix plc

Nuformix plc

NFX
Rang în acțiuni #20651
Nuformix plc operates in the field of pharmaceutical development for treating... Nuformix plc operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom. It offers NXP001, which has completed Phase 1 for use in oncology supportive care. The company is also developing NXP004, a novel form of Olaparib, which is in the IP generation phase for treating oncology; and NXP002 that is in pre-clinical stage for the treatment of idiopathic pulmonary fibrosis. It also has an option agreement with Oxilio Ltd. for NXP001 for oncology indications. Nuformix plc was founded in 2008 and is based in London, the United Kingdom.
Preț acțiune
$0.00244926
Capitalizare de piață
$51.67K
Schimbare (1 zi)
5.88%
Schimbare (1 an)
110.15%
Țară
GB
Tranzacționează Nuformix plc (NFX)

Categorie

EPS pentru Nuformix plc (NFX)
EPS la data de September 2025 TTM: $0.00
Conform celor mai recente rapoarte financiare și prețului acțiunilor Nuformix plc, EPS-ul actual al companiei (TTM) este $0.00. La sfârșitul anului 2024, compania avea un EPS de $-0.01 o scădere comparativ cu EPS-ului din 2023, care a fost de $0.00.
Istoricul EPS pentru Nuformix plc din 2014 până în 2026
EPS la sfârșitul fiecărui an
An EPS Schimbă
2026 (TTM) 0.00 -100.00%
2025 0.00 -100.00%
2024 $-0.01 520.00%
2023 0.00 -60.00%
2022 0.00 -16.67%
2021 0.00 50.00%
2020 0.00 -57.45%
2019 0.00 -31.88%
2018 $-0.01 -23.33%
2017 $-0.01 8.43%
2016 $-0.01 0.00%
2014 0.00 0.00%
EPS pentru companii similare sau concurente
Companie EPS Diferență EPS Țara
$3.62 -402,577.78%
DK
$15.47 -1,718,988.89%
US
$43.12 -4,791,211.11%
US
$9.62 -1,069,077.78%
BE
$2.98 -331,211.11%
AU